FDA orders new warnings on prostate cancer drugs
Links shared publicly online about this topic.
- 787total visits
FDA orders new warnings on prostate cancer drugs
View full resource at health.yahoo.net
Tags: Cancer, Cancer Medication, Prostate Cancer, Prostate Cancer Medication, Prostate, Drug, Men's Health, FDA
Most Recently Shared on October 20, 2010 at 10:07 pm By:
FDA orders new warnings on prostate cancer drugs: Certain hormone treatments for prostate cancer must carry new wa... http://bit.ly/czzEGz
High-Grade Prostate Cancer Risk Related to BPH Drugs
au.ibtimes.com — “US Food and Drug Administration (FDA) announced last June 9, 2011, that it has revised the Warnings and Precautions section of the labels for the 5-alpha reductase inhibitor (5-ARI) class of drugs to reflect new safety information about the increased risk of being diagnosed with a more serious form of prostate cancer (high grade prostate cancer). Drugs belonging to this class include finasteride 5mg (Proscar) and dudasteride (Avodart). Both drugs are currently approved for the management of ben.” View full resource at au.ibtimes.com
Most Recently Shared on June 14, 2011 at 12:11 pm By:
High-Grade Prostate Cancer Risk Related to BPH Drugs http://bit.ly/j5Gq2Y
FDA slaps cancer warning on prostate drugs - FiercePharma
fiercepharma.com — “Is a new FDA warning on prostate and hair loss drugs from Merck ($MRK) and GlaxoSmithKline ($GSK) warranted? The agency has announced that the drugs' labeling will include new cautionary language Read more...” View full resource at fiercepharma.com
Most Recently Shared on June 10, 2011 at 4:53 pm By:
FDA slaps cancer warning on prostate drugs http://bit.ly/in1ZUo
Do Merck, Glaxo Prostate Drugs Raise Cancer Risk? Maybe Not - Matthew Herper - The Medicine Show - Forbes
blogs.forbes.com — “Bloomberg reports: Merck & Co. and GlaxoSmithKline Plc (GSK)’s drugs for hair loss and enlarged prostate will carry new U.S. warnings about a low risk of being diagnosed with a more serious form of prostate cancer. The Food and Drug Administration revised the prescribing information for Merck’s Proscar and Propecia and Glaxo’s [...]” View full resource at blogs.forbes.com
Most Recently Shared on June 9, 2011 at 9:36 pm By:
Drugs and Devices OW OW Health
Do Merck, Glaxo Prostate Drugs Raise Cancer Risk? Maybe Not: The FDA issued a warning about what may be... http://onforb.es/ifpdLV #drug
FDA Drug Safety Communication: 5-alpha reductase inhibitors (5-ARIs) may increase the risk of a more serious form of prostate cancer
fda.gov — “[6-9-2011] The U.S. Food and Drug Administration (FDA) is informing healthcare professionals that the Warnings and Precautions section of the labels for the 5-alpha reductase inhibitor (5-ARI) class of drugs has been revised to include new safety information about the increased risk of being diagnosed with a more serious form of prostate cancer (high-grade prostate cancer).” View full resource at fda.gov
Most Recently Shared on June 9, 2011 at 4:27 pm By:
Dr Kelly Sennholz Physician, Doctor, Internist, and Emergency Physician
RT @medskep: 5-alpha reductase inhibitors (5-ARIs) may increase the risk of a more serious form of prostate cancer http://t.co/BJSCVcg
New warnings on class of prostate cancer drugs
prostate-report.org — “New warnings on class of prostate cancer drugs” View full resource at prostate-report.org
Most Recently Shared on December 18, 2010 at 5:33 pm By:
john clay mchugh Surgeon, Urologist, Physician, and Doctor
New warnings on class of prostate cancer drugs: The FDA requested that manufacturers add new warnings to labelin... http://bit.ly/emVX9t
FDA warns of prostate cancer drug risks - Food and Drug Administration Gossip
celebrifi.com — “FDA warns of prostate cancer drug risks - WASHINGTON | Thu Oct 21, 2010 1:45am BST WASHINGTON (Reuters) - Hormone treatments for Prostate Cancer need new warnings abou...” View full resource at celebrifi.com
Most Recently Shared on October 22, 2010 at 7:06 pm By:
john clay mchugh Surgeon, Urologist, Physician, and Doctor
FDA warns of prostate cancer drug risks: WASHINGTON | Thu Oct 21, 2010 1:45am BST WASHINGTON (Reuters) - Hormone... http://bit.ly/c9jJGo
FDA Requires New Safety Warnings for Certain Prostate Cancer Drugs -- AAFP News Now -- American Academy of Family Physicians
aafp.org — “The FDA is requiring manufacturers of gonadotropin-releasing hormone, or GnRH, agonists to update their products’ labeling with new safety information because the medications, which are used primarily to treat advanced prostate cancer, have been linked to increased risks of developing diabetes and cardiovascular disease.” View full resource at aafp.org
Most Recently Shared on October 22, 2010 at 4:35 am By:
FDA Requires New Safety Warnings for Certain Prostate Cancer Drugs http://bit.ly/bZ8eY7
FDA Calls for New Warnings on Some Prostate Ca... ( By Steven Reinberg HealthDay Rep...)
bio-medicine.org — “Health, By Steven Reinberg HealthDay Reporter ...WEDNESDAY Oct. 20 (HealthDay News) -- The U.S. Food and Drug Administ...The FDA first announced in May that it was reviewing the prostate canc...Hormone-based therapy is not a cure for prostate cancer because tumor...So should the new label warnings deter men from enrolling on hormone-...,FDA,Calls,for,New,Warnings,on,Some,Prostate,Cancer,Drugs,medicine,medical news today,latest medical news,medical newsletters,current medical news,latest medicine” View full resource at bio-medicine.org
Most Recently Shared on October 22, 2010 at 2:34 am By:
FDA Calls for New Warnings on Some Prostate Cancer Drugs http://bit.ly/aNof5P
FDA warns that some prostate cancer drugs may slightly raise risk of diabetes, heart disease - latimes.com
latimes.com — “If you're being treated for prostate cancer, don't be surprised to see new warnings on some of the meds you may be taking. Lupron, Zolodex and others have been linked to a slight increase in the risk of heart disease and diabetes, but it doesn't mean you should stop taking the drugs.” View full resource at latimes.com
Most Recently Shared on October 21, 2010 at 9:24 pm By:
LA Times Health News Health News
FDA warns that some prostate cancer drugs may slightly raise risk of diabetes, heart disease http://lat.ms/btc1t1
FDA Include warnings on risk for class of prostate cancer drugs
sciguru.com — “Science News: FDA asked manufacturers to add new warnings to labeling of gonadotropin-releasing hormone (GnRH) agonists, a class of drugs primarily used to treat men with prostate cancer.” View full resource at sciguru.com
Most Recently Shared on October 21, 2010 at 2:13 pm By:
john clay mchugh Surgeon, Urologist, Physician, and Doctor
FDA: Include warnings on risk for class of prostate cancer drugs (Science News and Information from SciGuru.com): ... http://bit.ly/c7HDiU
FDA: Include Warnings on Risk for Class of Prostate Cancer Drugs - Drugs.com MedNews
drugs.com — “The U.S. Food and Drug Administration today asked manufacturers to add new warnings to labeling of gonadotropin-releasing hormone (GnRH) agonists, a class of dr” View full resource at drugs.com
Most Recently Shared on October 21, 2010 at 1:15 pm By:
Drugs and Devices OW OW Health
FDA: Include Warnings on Risk for Class of Prostate Cancer Drugs: ROCKVILLE, Md., Oct. 20, 2010--The U.S. Foo... http://bit.ly/cJjQOT #drug
FDA Recommends New Warnings For Prostate Cancer Treatment - OzarksFirst.com
ozarksfirst.com — “(Washington, DC) -- The Food and Drug Administration is suggesting new warnings for hormone treatments used for prostate cancer patients.” View full resource at ozarksfirst.com
Most Recently Shared on October 21, 2010 at 3:34 am By:
FDA Recommends New Warnings For Prostate Cancer Treatment http://bit.ly/9tfTYT
FDA Calls for New Warnings on Some Prostate Cancer Drugs - Drugs.com MedNews
drugs.com — “The U.S. Food and Drug Administration on Wednesday called for new warnings on the labels of widely used hormonal prostate cancer drugs because of evidence of a” View full resource at drugs.com
Most Recently Shared on October 21, 2010 at 2:07 am By:
FDA Calls for New Warnings on Some Prostate Cancer Drugs - http://bit.ly/9gQegt
FDA warns of prostate cancer drug risks | Reuters
reuters.com — “WASHINGTON (Reuters) - Hormone treatments for prostate cancer need new warnings about a small increased risk of diabetes and heart problems including sudden death, U.S. health officials said on Wednesday. The” View full resource at reuters.com
Most Recently Shared on October 21, 2010 at 1:25 am By:
Bruce McLucas, MD Doctor, ObGyn Physician, Surgeon, and Physician
FDA warns of prostate cancer drug risks http://ow.ly/19yt8p
FDA warns of prostate cancer drug risks | Reuters
reuters.com — “WASHINGTON (Reuters) - Hormone treatments for prostate cancer need new warnings about a small increased risk of diabetes and heart problems including sudden death, U.S. health officials said on Wednesday. The” View full resource at reuters.com
Most Recently Shared on October 21, 2010 at 1:00 am By:
FDA warns of prostate cancer drug risks http://dlvr.it/7Jcyw
Advertisement
